Cargando…
Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer
BACKGROUND: Bladder cancer is a very common urological cancer globally, and cisplatin- or gemcitabine-based chemotherapy is essential for advanced bladder cancer patients. Many patients with bladder cancer have a relatively poor response to chemotherapy, leading to failure of clinical treatment. We...
Autores principales: | Li, Yangle, Zu, Xiongbing, Hu, Xiheng, Wang, Long, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894368/ https://www.ncbi.nlm.nih.gov/pubmed/31761897 http://dx.doi.org/10.12659/MSM.917345 |
Ejemplares similares
-
Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis
por: Zhang, Huihui, et al.
Publicado: (2014) -
Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein
por: Wang, Huaiming, et al.
Publicado: (2019) -
Forkhead Box Protein J1 (FOXJ1) is Overexpressed in Colorectal Cancer and Promotes Nuclear Translocation of β-Catenin in SW620 Cells
por: Liu, Kuiliang, et al.
Publicado: (2017) -
Longevity-Associated Forkhead Box O3 (FOXO3) Single Nucleotide Polymorphisms are Associated with Type 2 Diabetes Mellitus in Chinese Elderly Women
por: Mao, Yu-Qin, et al.
Publicado: (2019) -
Knockdown of TCTN1 Strongly Decreases Growth of Human Colon Cancer Cells
por: Dai, Xiaoyu, et al.
Publicado: (2017)